{"transactions":[{"id":4638090,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:29:22.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":48199,"price":18.1,"value":872401.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.87 to $18.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":471301,"source":{"system":"sec-edgar","filing":"0001193125-26-418096","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526418096/ownership.xml","form_type":"4"}},{"id":4638089,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-08T21:29:11.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":206,"price":19.26,"value":3967.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $19.20 to $19.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,538 shares underlying restricted stock units."}],"balance_after":105134,"source":{"system":"sec-edgar","filing":"0001193125-26-418094","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526418094/ownership.xml","form_type":"4"}},{"id":4638088,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-08T21:29:11.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":17511,"price":18.58,"value":325354.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.20 to $19.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,538 shares underlying restricted stock units."}],"balance_after":105340,"source":{"system":"sec-edgar","filing":"0001193125-26-418094","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526418094/ownership.xml","form_type":"4"}},{"id":4613319,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2026-09-09T20:17:07.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":8530,"price":18.97,"value":161814.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.56 to $19.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 10,025 shares underlying restricted stock units."}],"balance_after":399130,"source":{"system":"sec-edgar","filing":"0001193125-26-386473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526386473/ownership.xml","form_type":"4"}},{"id":4613311,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-09T20:15:31.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":17717,"price":18.94,"value":335559.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.34 to $19.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,538 shares underlying restricted stock units."}],"balance_after":122851,"source":{"system":"sec-edgar","filing":"0001193125-26-386464","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526386464/ownership.xml","form_type":"4"}},{"id":4613275,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-09T20:12:38.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":48199,"price":18.94,"value":912889.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.33 to $19.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":519500,"source":{"system":"sec-edgar","filing":"0001193125-26-386455","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526386455/ownership.xml","form_type":"4"}},{"id":673132,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-08-28T16:43:41.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":4508,"price":20.03,"value":90295.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.00 to $20.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,102 shares underlying restricted stock units."}],"balance_after":223657,"source":{"system":"sec-edgar","filing":"0001193125-26-374645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526374645/ownership.xml","form_type":"4"}},{"id":673048,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18754,"kind":"organization","name":"SVF Pauling (Cayman) Ltd","position":1,"cik":"0001817592","reported_name":"SVF Pauling (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18755,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M2) L.P.","position":2,"cik":"0001805808","reported_name":"SOFTBANK VISION FUND (AIV M2) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T09:01:36.000Z","date":"2026-08-25","kind":"sale","planned":false,"acquired":false,"shares":6000000,"price":19.4,"value":116400000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. (\"AIV M2\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing AIV M2 in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of AIV M2, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF Pauling (Cayman) Limited's investments."}],"balance_after":21904963,"source":{"system":"sec-edgar","filing":"0001493152-26-040513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817592/000149315226040513/ownership.xml","form_type":"4"}},{"id":684475,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-18T20:17:50.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":48199,"price":20.33,"value":979885.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $19.56 to $20.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":567699,"source":{"system":"sec-edgar","filing":"0001193125-26-355502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526355502/ownership.xml","form_type":"4"}},{"id":683661,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-18T20:16:27.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":17717,"price":19.74,"value":349733.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $19.51 to $19.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,538 shares underlying restricted stock units."}],"balance_after":140568,"source":{"system":"sec-edgar","filing":"0001193125-26-355493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526355493/ownership.xml","form_type":"4"}},{"id":700745,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:13:47.000Z","date":"2026-07-28","kind":"sale","planned":false,"acquired":false,"shares":1459,"price":18.61,"value":27151.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 3,269 shares of restricted stock units (\"RSUs\") on July 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,538 shares underlying RSUs."}],"balance_after":158285,"source":{"system":"sec-edgar","filing":"0001193125-26-326144","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526326144/ownership.xml","form_type":"4"}},{"id":700793,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-07-30T20:13:22.000Z","date":"2026-07-28","kind":"sale","planned":false,"acquired":false,"shares":748,"price":18.61,"value":13920.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 3,051 shares of restricted stock units (\"RSUs\") on July 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,102 shares underlying RSUs."}],"balance_after":228165,"source":{"system":"sec-edgar","filing":"0001193125-26-326142","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526326142/ownership.xml","form_type":"4"}},{"id":700720,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2026-07-30T20:12:40.000Z","date":"2026-07-28","kind":"sale","planned":false,"acquired":false,"shares":2237,"price":18.61,"value":41630.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,012 shares of restricted stock units (\"RSUs\") on July 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,025 shares underlying RSUs."}],"balance_after":407660,"source":{"system":"sec-edgar","filing":"0001193125-26-326137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526326137/ownership.xml","form_type":"4"}},{"id":712677,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2026-07-08T21:11:17.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":8660,"price":18.71,"value":162028.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.45 to $19.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 15,037 shares underlying restricted stock units."}],"balance_after":409897,"source":{"system":"sec-edgar","filing":"0001193125-26-298688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526298688/ownership.xml","form_type":"4"}},{"id":713120,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-08T21:08:20.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":48199,"price":19.58,"value":943736.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $18.52 to $20.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":615898,"source":{"system":"sec-edgar","filing":"0001193125-26-298681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526298681/ownership.xml","form_type":"4"}},{"id":713119,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-08T21:08:20.000Z","date":"2026-06-30","kind":"grant","planned":true,"acquired":true,"shares":3056,"price":6.95,"value":21239.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on January 2, 2026."}],"balance_after":664097,"source":{"system":"sec-edgar","filing":"0001193125-26-298681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526298681/ownership.xml","form_type":"4"}},{"id":712697,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-08T21:07:18.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":17717,"price":18.69,"value":331130.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.39 to $19.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":159744,"source":{"system":"sec-edgar","filing":"0001193125-26-298679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526298679/ownership.xml","form_type":"4"}},{"id":718499,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-07-02T20:12:40.000Z","date":"2026-06-30","kind":"grant","planned":true,"acquired":true,"shares":3056,"price":6.95,"value":21239.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on January 2, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,153 shares underlying restricted stock units."}],"balance_after":228913,"source":{"system":"sec-edgar","filing":"0001193125-26-294528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526294528/ownership.xml","form_type":"4"}},{"id":718498,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-07-02T20:12:40.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":19.09,"value":954500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.66 to $19.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,153 shares underlying restricted stock units."}],"balance_after":225857,"source":{"system":"sec-edgar","filing":"0001193125-26-294528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526294528/ownership.xml","form_type":"4"}},{"id":727780,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":51560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 10, 2025, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":223440,"derivative":{"exercise_price":4.45,"expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":51560},"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727779,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":61563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 2, 2020, the reporting person was granted an option to purchase 63,363 shares of common stock, subject to determination by the Board of Directors of the Issuer (the \"Board\") that the Issuer met, in whole or in part, certain milestones (the \"2020 Option Grant Criteria\"). On June 23, 2020, the Board determined that the 2020 Option Grant Criteria related to 25% of the option had been achieved, and the shares underlying 25% of this option, or 15,841 shares, commenced vesting in sixteen (16) equal quarterly installments following September 23, 2020. On December 11, 2020, the Board determined that the 2020 Option Grant Criteria related to the remaining 75% of the option had been achieved. The shares underlying 75% of this option, or 47,522 shares, vested in sixteen (16) equal quarterly installments following March 11, 2021."}],"balance_after":0,"derivative":{"exercise_price":5.22,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":61563},"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727778,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":56323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this stock option vested in sixteen (16) equal quarterly installments following the vesting commencement date of April 23, 2019."}],"balance_after":0,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":56323},"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727777,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":51560,"price":16.97,"value":874973.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $16.15 to $17.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":177461,"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727776,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":51560,"price":4.45,"value":229442.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":229021,"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727775,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":61563,"price":16.97,"value":1044724.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $16.15 to $17.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":177461,"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727774,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":61563,"price":5.22,"value":321358.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":239024,"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727773,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":56323,"price":16.97,"value":955801.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $16.15 to $17.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":177461,"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727772,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":56323,"price":5.04,"value":283867.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":233784,"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727771,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:57.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":17717,"price":17.01,"value":301366.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $16.38 to $17.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":177461,"source":{"system":"sec-edgar","filing":"0001193125-26-281061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526281061/ownership.xml","form_type":"4"}},{"id":727750,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:09:22.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":93456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder vested in equal quarterly installments over the remaining thirty-six (36) months."}],"balance_after":0,"derivative":{"exercise_price":4.12,"expiration_date":"2028-04-09","underlying":"Common Stock","underlying_shares":93456},"source":{"system":"sec-edgar","filing":"0001193125-26-281059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526281059/ownership.xml","form_type":"4"}},{"id":727749,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:22.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":93456,"price":16.94,"value":1583144.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $16.15 to $17.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,037 shares underlying restricted stock units."}],"balance_after":418557,"source":{"system":"sec-edgar","filing":"0001193125-26-281059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526281059/ownership.xml","form_type":"4"}},{"id":727748,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2026-06-24T20:09:22.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":93456,"price":4.12,"value":385038.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,037 shares underlying restricted stock units."}],"balance_after":512013,"source":{"system":"sec-edgar","filing":"0001193125-26-281059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526281059/ownership.xml","form_type":"4"}},{"id":743429,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":24229,"kind":"person","name":"Mazumdar Claire","position":1,"cik":"0002034671","reported_name":"Mazumdar Claire","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:11.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034671/000119312526265913/ownership.xml","form_type":"4"}},{"id":743257,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":36338,"kind":"person","name":"Dable Habib J","position":1,"cik":"0001690773","reported_name":"Dable Habib J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:10.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526265911/ownership.xml","form_type":"4"}},{"id":743526,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39749,"kind":"person","name":"HILL LINDA A","position":1,"cik":"0001130483","reported_name":"HILL LINDA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:07.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130483/000119312526265907/ownership.xml","form_type":"4"}},{"id":743258,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":35925,"kind":"person","name":"Borisy Alexis","position":1,"cik":"0001319446","reported_name":"Borisy Alexis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:06.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526265906/ownership.xml","form_type":"4"}},{"id":743256,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:04.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265905","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526265905/ownership.xml","form_type":"4"}},{"id":743264,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:03.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265904","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000119312526265904/ownership.xml","form_type":"4"}},{"id":743255,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39692,"kind":"person","name":"COATS LONNEL","position":1,"cik":"0001612528","reported_name":"COATS LONNEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:30:03.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":32947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2026 with respect to 32,947 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":32947,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":32947},"source":{"system":"sec-edgar","filing":"0001193125-26-265908","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526265908/ownership.xml","form_type":"4"}},{"id":779355,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-14T22:44:36.000Z","date":"2026-05-14","kind":"sale","planned":true,"acquired":false,"shares":17717,"price":12.86,"value":227840.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.67 to $13.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,807 shares underlying restricted stock units."}],"balance_after":195178,"source":{"system":"sec-edgar","filing":"0001193125-26-224545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526224545/ownership.xml","form_type":"4"}},{"id":796959,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-30T20:22:54.000Z","date":"2026-04-28","kind":"sale","planned":false,"acquired":false,"shares":972,"price":14.79,"value":14375.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 3,268 shares of restricted stock units (\"RSUs\") on April 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,807 shares underlying RSUs."}],"balance_after":212895,"source":{"system":"sec-edgar","filing":"0001193125-26-197419","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526197419/ownership.xml","form_type":"4"}},{"id":797086,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-04-30T20:22:24.000Z","date":"2026-04-28","kind":"sale","planned":false,"acquired":false,"shares":753,"price":14.79,"value":11136.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 3,051 shares of restricted stock units (\"RSUs\") on April 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,153 shares underlying RSUs."}],"balance_after":275857,"source":{"system":"sec-edgar","filing":"0001193125-26-197415","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526197415/ownership.xml","form_type":"4"}},{"id":796936,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2026-04-30T20:20:04.000Z","date":"2026-04-28","kind":"sale","planned":false,"acquired":false,"shares":1490,"price":14.79,"value":22037.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,012 shares of restricted stock units (\"RSUs\") on April 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,037 shares underlying RSUs."}],"balance_after":418557,"source":{"system":"sec-edgar","filing":"0001193125-26-197395","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526197395/ownership.xml","form_type":"4"}},{"id":811560,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-10T00:55:01.000Z","date":"2026-04-09","kind":"exercise","planned":true,"acquired":false,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 2, 2020, the reporting person was granted an option to purchase 63,363 shares of common stock, subject to determination by the Board of Directors of the Issuer (the \"Board\") that the Issuer met, in whole or in part, certain milestones (the \"2020 Option Grant Criteria\"). On June 23, 2020, the Board determined that the 2020 Option Grant Criteria related to 25% of the option had been achieved, and the shares underlying 25% of this option, or 15,841 shares, commenced vesting in sixteen (16) equal quarterly installments following September 23, 2020. On December 11, 2020, the Board determined that the 2020 Option Grant Criteria related to the remaining 75% of the option had been achieved. The shares underlying 75% of this option, or 47,522 shares, vested in sixteen (16) equal quarterly installments following March 11, 2021."}],"balance_after":61563,"derivative":{"exercise_price":5.22,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0001193125-26-150044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526150044/ownership.xml","form_type":"4"}},{"id":811559,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-10T00:55:01.000Z","date":"2026-04-09","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":15,"value":27000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 13,075 shares underlying restricted stock units."}],"balance_after":213867,"source":{"system":"sec-edgar","filing":"0001193125-26-150044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526150044/ownership.xml","form_type":"4"}},{"id":811558,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-10T00:55:01.000Z","date":"2026-04-09","kind":"exercise","planned":true,"acquired":true,"shares":1800,"price":5.22,"value":9396.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 13,075 shares underlying restricted stock units."}],"balance_after":215667,"source":{"system":"sec-edgar","filing":"0001193125-26-150044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526150044/ownership.xml","form_type":"4"}},{"id":811557,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-10T00:55:01.000Z","date":"2026-04-07","kind":"sale","planned":true,"acquired":false,"shares":17717,"price":13.01,"value":230498.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.42 to $13.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 13,075 shares underlying restricted stock units."}],"balance_after":213867,"source":{"system":"sec-edgar","filing":"0001193125-26-150044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526150044/ownership.xml","form_type":"4"}},{"id":848807,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-11T20:30:35.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":17717,"price":10.06,"value":178233.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.77 to $10.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 13,075 shares underlying restricted stock units."}],"balance_after":231584,"source":{"system":"sec-edgar","filing":"0001193125-26-102270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526102270/ownership.xml","form_type":"4"}},{"id":927935,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2026-01-29T21:22:47.000Z","date":"2026-01-28","kind":"sale","planned":false,"acquired":false,"shares":2686,"price":8.45,"value":22696.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 9,072 shares of RSUs on January 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 20,049 shares underlying RSUs."}],"balance_after":420047,"source":{"system":"sec-edgar","filing":"0001193125-26-029415","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526029415/ownership.xml","form_type":"4"}},{"id":927934,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2026-01-29T21:22:47.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":18895,"price":7.62,"value":143979.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 59,550 shares of restricted stock units (\"RSUs\") on January 26, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 29,121 shares underlying RSUs."}],"balance_after":422733,"source":{"system":"sec-edgar","filing":"0001193125-26-029415","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526029415/ownership.xml","form_type":"4"}},{"id":927978,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-01-29T21:22:30.000Z","date":"2026-01-28","kind":"sale","planned":false,"acquired":false,"shares":1354,"price":8.45,"value":11441.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of RSUs on January 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 12,204 shares underlying RSUs."}],"balance_after":276610,"source":{"system":"sec-edgar","filing":"0001193125-26-029412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526029412/ownership.xml","form_type":"4"}},{"id":927977,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-01-29T21:22:30.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":11684,"price":7.62,"value":89032.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,394 shares of RSUs on January 26, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 17,710 shares underlying RSUs."}],"balance_after":277964,"source":{"system":"sec-edgar","filing":"0001193125-26-029412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526029412/ownership.xml","form_type":"4"}},{"id":927976,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-01-29T21:22:30.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":994,"price":2.99,"value":2972.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 108,919 shares underlying restricted stock units (\"RSUs\")."}],"balance_after":338463,"source":{"system":"sec-edgar","filing":"0001193125-26-029412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526029412/ownership.xml","form_type":"4"}},{"id":927940,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-29T21:20:25.000Z","date":"2026-01-28","kind":"sale","planned":false,"acquired":false,"shares":1695,"price":8.45,"value":14322.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,724 shares of RSUs on January 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 13,075 shares underlying RSUs."}],"balance_after":249301,"source":{"system":"sec-edgar","filing":"0001193125-26-029403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526029403/ownership.xml","form_type":"4"}},{"id":927939,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-29T21:20:25.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":13820,"price":7.62,"value":105308.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,394 shares of restricted stock units (\"RSUs\") on January 26, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,799 shares underlying RSUs."}],"balance_after":250996,"source":{"system":"sec-edgar","filing":"0001193125-26-029403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526029403/ownership.xml","form_type":"4"}},{"id":938531,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-15T21:13:56.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 13, 2026, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":575000,"derivative":{"exercise_price":7.94,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001193125-26-014111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312526014111/ownership.xml","form_type":"4"}},{"id":938582,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-15T21:13:45.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 13, 2026, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":475000,"derivative":{"exercise_price":7.94,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001193125-26-014110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312526014110/ownership.xml","form_type":"4"}},{"id":938758,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-15T21:13:30.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":1450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 13, 2026, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":1450000,"derivative":{"exercise_price":7.94,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":1450000},"source":{"system":"sec-edgar","filing":"0001193125-26-014109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526014109/ownership.xml","form_type":"4"}},{"id":938533,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-15T21:12:54.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 13, 2026, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":400000,"derivative":{"exercise_price":7.94,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001193125-26-014106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312526014106/ownership.xml","form_type":"4"}},{"id":945155,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-07T21:15:03.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":43168,"price":7.82,"value":337573.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,854 shares of RSUs on January 5, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."}],"balance_after":661041,"source":{"system":"sec-edgar","filing":"0001193125-26-006328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526006328/ownership.xml","form_type":"4"}},{"id":945154,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-07T21:15:03.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":994,"price":2.99,"value":2972.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 136,854 shares underlying restricted stock units (\"RSUs\")."}],"balance_after":704209,"source":{"system":"sec-edgar","filing":"0001193125-26-006328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526006328/ownership.xml","form_type":"4"}},{"id":1005865,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39692,"kind":"person","name":"COATS LONNEL","position":1,"cik":"0001612528","reported_name":"COATS LONNEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-06T21:37:03.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":207931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments after November 4, 2025, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":207931,"derivative":{"exercise_price":6.86,"expiration_date":"2035-11-03","underlying":"Common Stock","underlying_shares":207931},"source":{"system":"sec-edgar","filing":"0001193125-25-269790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312525269790/ownership.xml","form_type":"4"}},{"id":1005864,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":36338,"kind":"person","name":"Dable Habib J","position":1,"cik":"0001690773","reported_name":"Dable Habib J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-06T21:33:51.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":207931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments after November 4, 2025, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":207931,"derivative":{"exercise_price":6.86,"expiration_date":"2035-11-03","underlying":"Common Stock","underlying_shares":207931},"source":{"system":"sec-edgar","filing":"0001193125-25-269769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312525269769/ownership.xml","form_type":"4"}},{"id":1008805,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-04T21:10:37.000Z","date":"2025-11-03","kind":"sale","planned":false,"acquired":false,"shares":62073,"price":7,"value":434511.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,853 shares of restricted stock units (\"RSUs\") on October 31, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 136,854 shares underlying RSUs."}],"balance_after":703215,"source":{"system":"sec-edgar","filing":"0001193125-25-264700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312525264700/ownership.xml","form_type":"4"}},{"id":1011444,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-10-30T20:19:46.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":21394,"price":7.5,"value":160455.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.49 to $7.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 108,919 shares underlying RSUs."}],"balance_after":337469,"source":{"system":"sec-edgar","filing":"0001193125-25-258595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312525258595/ownership.xml","form_type":"4"}},{"id":1011443,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-10-30T20:19:46.000Z","date":"2025-10-28","kind":"sale","planned":false,"acquired":false,"shares":19135,"price":7.29,"value":139494.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 47,897 shares of restricted stock units (\"RSUs\") on October 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 108,919 shares underlying RSUs."}],"balance_after":358863,"source":{"system":"sec-edgar","filing":"0001193125-25-258595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000119312525258595/ownership.xml","form_type":"4"}},{"id":1011416,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-30T20:15:39.000Z","date":"2025-10-28","kind":"sale","planned":false,"acquired":false,"shares":21664,"price":7.29,"value":157930.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 48,115 shares of restricted stock units (\"RSUs\") on October 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 110,008 shares underlying RSUs."}],"balance_after":313631,"source":{"system":"sec-edgar","filing":"0001193125-25-258574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000119312525258574/ownership.xml","form_type":"4"}},{"id":1011380,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2025-10-30T20:12:45.000Z","date":"2025-10-28","kind":"sale","planned":false,"acquired":false,"shares":30897,"price":7.29,"value":225239.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 68,622 shares of restricted stock units (\"RSUs\") on October 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 168,866 shares underlying RSUs."}],"balance_after":521823,"source":{"system":"sec-edgar","filing":"0001193125-25-258557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000119312525258557/ownership.xml","form_type":"4"}},{"id":1079250,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-07-30T20:54:35.000Z","date":"2025-07-29","kind":"sale","planned":false,"acquired":false,"shares":15724,"price":3.68,"value":57864.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,393 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 156,816 shares underlying RSUs."}],"balance_after":377998,"source":{"system":"sec-edgar","filing":"0000950170-25-100367","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000095017025100367/ownership.xml","form_type":"4"}},{"id":1079249,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-07-30T20:54:35.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":1359,"price":3.74,"value":5082.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units (\"RSUs\") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 199,209 shares underlying RSUs."}],"balance_after":393722,"source":{"system":"sec-edgar","filing":"0000950170-25-100367","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000095017025100367/ownership.xml","form_type":"4"}},{"id":1079224,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-30T20:54:19.000Z","date":"2025-07-29","kind":"sale","planned":false,"acquired":false,"shares":18380,"price":3.68,"value":67638.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,393 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 158,123 shares underlying RSUs."}],"balance_after":335295,"source":{"system":"sec-edgar","filing":"0000950170-25-100366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000095017025100366/ownership.xml","form_type":"4"}},{"id":1079223,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-30T20:54:19.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":1701,"price":3.74,"value":6361.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,724 shares of restricted stock units (\"RSUs\") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 200,516 shares underlying RSUs."}],"balance_after":353675,"source":{"system":"sec-edgar","filing":"0000950170-25-100366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000095017025100366/ownership.xml","form_type":"4"}},{"id":1079192,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2025-07-30T20:54:05.000Z","date":"2025-07-29","kind":"sale","planned":false,"acquired":false,"shares":26701,"price":3.68,"value":98259.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 59,550 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 237,488 shares underlying RSUs."}],"balance_after":552720,"source":{"system":"sec-edgar","filing":"0000950170-25-100365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025100365/ownership.xml","form_type":"4"}},{"id":1079191,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2025-07-30T20:54:05.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":4069,"price":3.74,"value":15218.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 9,072 shares of restricted stock units (\"RSUs\") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 297,038 shares underlying RSUs."}],"balance_after":579421,"source":{"system":"sec-edgar","filing":"0000950170-25-100365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025100365/ownership.xml","form_type":"4"}},{"id":1079189,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-30T20:53:41.000Z","date":"2025-07-29","kind":"sale","planned":false,"acquired":false,"shares":18276,"price":3.68,"value":67255.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,393 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 144,611 shares underlying RSUs."}],"balance_after":371472,"source":{"system":"sec-edgar","filing":"0000950170-25-100364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025100364/ownership.xml","form_type":"4"}},{"id":1079188,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-30T20:53:41.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":1637,"price":3.74,"value":6122.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units (\"RSUs\") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 187,004 shares underlying RSUs."}],"balance_after":389748,"source":{"system":"sec-edgar","filing":"0000950170-25-100364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025100364/ownership.xml","form_type":"4"}},{"id":1089700,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-10T20:55:22.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":18639,"price":3.57,"value":66541.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 41,558 shares of RSUs on July 8, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 273,707 shares underlying RSUs."}],"balance_after":765288,"source":{"system":"sec-edgar","filing":"0000950170-25-095093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025095093/ownership.xml","form_type":"4"}},{"id":1089699,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-10T20:55:22.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":42740,"price":3.57,"value":152581.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 95,295 shares of restricted stock units (\"RSUs\") on July 8, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 315,265 shares underlying RSUs."}],"balance_after":783927,"source":{"system":"sec-edgar","filing":"0000950170-25-095093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025095093/ownership.xml","form_type":"4"}},{"id":1098078,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-07-01T21:00:16.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.94,"value":14700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 204,715 shares underlying RSUs."}],"balance_after":395081,"source":{"system":"sec-edgar","filing":"0000950170-25-092315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000095017025092315/ownership.xml","form_type":"4"}},{"id":1098496,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-01T20:59:29.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.94,"value":14700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 410,560 shares underlying RSUs."}],"balance_after":826667,"source":{"system":"sec-edgar","filing":"0000950170-25-092305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025092305/ownership.xml","form_type":"4"}},{"id":1115303,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":24229,"kind":"person","name":"Mazumdar Claire","position":1,"cik":"0002034671","reported_name":"Mazumdar Claire","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-11T20:16:25.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":421241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments after June 9, 2025, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":421241,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-08","underlying":"Common Stock","underlying_shares":421241},"source":{"system":"sec-edgar","filing":"0000950170-25-084838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034671/000095017025084838/ownership.xml","form_type":"4"}},{"id":1120079,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39749,"kind":"person","name":"HILL LINDA A","position":1,"cik":"0001130483","reported_name":"HILL LINDA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:52:59.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":136681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":136681,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":136681},"source":{"system":"sec-edgar","filing":"0000950170-25-083314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130483/000095017025083314/ownership.xml","form_type":"4"}},{"id":1119830,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":35925,"kind":"person","name":"Borisy Alexis","position":1,"cik":"0001319446","reported_name":"Borisy Alexis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:52:37.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":136681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":136681,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":136681},"source":{"system":"sec-edgar","filing":"0000950170-25-083312","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025083312/ownership.xml","form_type":"4"}},{"id":1119829,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:51:59.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":136681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":136681,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":136681},"source":{"system":"sec-edgar","filing":"0000950170-25-083311","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025083311/ownership.xml","form_type":"4"}},{"id":1119904,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":75000,"kind":"person","name":"Kathiresan Sekar","position":1,"cik":"0001864112","reported_name":"Kathiresan Sekar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:51:29.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":136681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":136681,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":136681},"source":{"system":"sec-edgar","filing":"0000950170-25-083310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864112/000095017025083310/ownership.xml","form_type":"4"}},{"id":1119852,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":39696,"kind":"person","name":"Murcko Mark","position":1,"cik":"0001816130","reported_name":"Murcko Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:51:09.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":136681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":136681,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":136681},"source":{"system":"sec-edgar","filing":"0000950170-25-083306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816130/000095017025083306/ownership.xml","form_type":"4"}},{"id":1119854,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":78793,"kind":"person","name":"Rubin Jami","position":1,"cik":"0001816484","reported_name":"Rubin Jami","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T17:50:40.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":136681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2025 with respect to 136,681 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date."}],"balance_after":136681,"derivative":{"exercise_price":3.36,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":136681},"source":{"system":"sec-edgar","filing":"0000950170-25-083305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816484/000095017025083305/ownership.xml","form_type":"4"}},{"id":1163454,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-05-01T00:25:38.000Z","date":"2025-04-30","kind":"sale","planned":false,"acquired":false,"shares":10739,"price":3,"value":32217.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,392 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 204,715 shares underlying RSUs."}],"balance_after":390081,"source":{"system":"sec-edgar","filing":"0000950170-25-061367","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000095017025061367/ownership.xml","form_type":"4"}},{"id":1163453,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18784,"kind":"person","name":"Rahmer Peter","position":1,"cik":"0001959229","reported_name":"Rahmer Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-05-01T00:25:38.000Z","date":"2025-04-28","kind":"sale","planned":false,"acquired":false,"shares":1364,"price":3.17,"value":4323.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units (\"RSUs\") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 247,107 shares underlying RSUs."}],"balance_after":400820,"source":{"system":"sec-edgar","filing":"0000950170-25-061367","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959229/000095017025061367/ownership.xml","form_type":"4"}},{"id":1163427,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-01T00:24:39.000Z","date":"2025-04-30","kind":"sale","planned":true,"acquired":false,"shares":12943,"price":3,"value":38829.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,392 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 206,240 shares underlying RSUs."}],"balance_after":355376,"source":{"system":"sec-edgar","filing":"0000950170-25-061366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000095017025061366/ownership.xml","form_type":"4"}},{"id":1163426,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-01T00:24:39.000Z","date":"2025-04-29","kind":"sale","planned":true,"acquired":false,"shares":3558,"price":3.23,"value":11492.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 248,632 shares underlying RSUs."}],"balance_after":368319,"source":{"system":"sec-edgar","filing":"0000950170-25-061366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000095017025061366/ownership.xml","form_type":"4"}},{"id":1163425,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-01T00:24:39.000Z","date":"2025-04-28","kind":"sale","planned":true,"acquired":false,"shares":981,"price":3.17,"value":3109.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 248,632 shares underlying RSUs."}],"balance_after":371877,"source":{"system":"sec-edgar","filing":"0000950170-25-061366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000095017025061366/ownership.xml","form_type":"4"}},{"id":1163424,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22284,"kind":"person","name":"Catinazzo Thomas","position":1,"cik":"0001818261","reported_name":"Catinazzo Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-01T00:24:39.000Z","date":"2025-04-28","kind":"sale","planned":true,"acquired":false,"shares":1709,"price":3.17,"value":5417.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,722 shares of restricted stock units (\"RSUs\") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 248,632 shares underlying RSUs."}],"balance_after":372858,"source":{"system":"sec-edgar","filing":"0000950170-25-061366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818261/000095017025061366/ownership.xml","form_type":"4"}},{"id":1163402,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2025-05-01T00:24:14.000Z","date":"2025-04-30","kind":"sale","planned":false,"acquired":false,"shares":27472,"price":3,"value":82416.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 59,550 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 306,110 shares underlying RSUs."}],"balance_after":583490,"source":{"system":"sec-edgar","filing":"0000950170-25-061365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025061365/ownership.xml","form_type":"4"}},{"id":1163401,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2025-05-01T00:24:14.000Z","date":"2025-04-28","kind":"sale","planned":false,"acquired":false,"shares":4090,"price":3.17,"value":12965.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 9,071 shares of restricted stock units (\"RSUs\") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 365,660 shares underlying RSUs."}],"balance_after":610962,"source":{"system":"sec-edgar","filing":"0000950170-25-061365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025061365/ownership.xml","form_type":"4"}},{"id":1163400,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-01T00:23:52.000Z","date":"2025-04-30","kind":"sale","planned":false,"acquired":false,"shares":12943,"price":3,"value":38829.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,392 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 192,510 shares underlying RSUs."}],"balance_after":391385,"source":{"system":"sec-edgar","filing":"0000950170-25-061364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025061364/ownership.xml","form_type":"4"}},{"id":1163399,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-01T00:23:52.000Z","date":"2025-04-28","kind":"sale","planned":false,"acquired":false,"shares":1644,"price":3.17,"value":5211.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units (\"RSUs\") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 234,902 shares underlying RSUs."}],"balance_after":404328,"source":{"system":"sec-edgar","filing":"0000950170-25-061364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025061364/ownership.xml","form_type":"4"}},{"id":1166749,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-24T20:03:43.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":18653,"price":2.97,"value":55399.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 41,558 shares of RSUs on April 22, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 410,560 shares underlying RSUs."}],"balance_after":821667,"source":{"system":"sec-edgar","filing":"0000950170-25-057996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025057996/ownership.xml","form_type":"4"}},{"id":1166748,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-24T20:03:43.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":42769,"price":2.97,"value":127023.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 95,295 shares of restricted stock units (\"RSUs\") on April 22, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 452,118 shares underlying RSUs."}],"balance_after":840320,"source":{"system":"sec-edgar","filing":"0000950170-25-057996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025057996/ownership.xml","form_type":"4"}},{"id":1188045,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":27787,"kind":"person","name":"Bergstrom Donald A","position":1,"cik":"0001709772","reported_name":"Bergstrom Donald A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2025-03-31T20:19:25.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":986,"price":2.84,"value":2800.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,188 shares of restricted stock units (\"RSUs\") on March 26, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 374,731 shares underlying RSUs."}],"balance_after":615052,"source":{"system":"sec-edgar","filing":"0000950170-25-047762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025047762/ownership.xml","form_type":"4"}}],"next_cursor":"2025-03-31T20:19:25.000000Z,1188045"}